Skip to main content
. 2021 Dec 14;11:763687. doi: 10.3389/fcimb.2021.763687

Figure 2.

Figure 2

Schematic representation of mechanisms of action of COVID-19 therapeutics by inhibiting endocytosis, ACE2 receptor, and viral replication. COVID-19, coronavirus disease 2019; ACE2, angiotensin-converting enzyme 2.